Back
Heartland Financial USA Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Sell
48
HTLF
Heartland Financial USA
Last Price:
55.95
Seasonality Move:
5.97%
Sell
35
RARE
Ultragenyx Pharmaceutical
Last Price:
54.41
Seasonality Move:
7.55%
Sell
48
Heartland Financial USA (HTLF)
is a Sell
Is Heartland Financial USA a Buy, Sell or Hold?
- The current Heartland Financial USA [HTLF] share price is $56.00. The Score for HTLF is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- HTLF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $54.43. The Score for RARE is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
HTLF Stock Price Chart
What is Heartland Financial USA's stock price today?
-
The Heartland Financial USA share price today is $56.00
The current trend is moderately bullish and HTLF is experiencing slight buying pressure.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $54.43
The current trend is moderately bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.
HTLF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.92 | Buy |
Relative Strength Index (14 RSI): | 54.35 | Buy |
Chaikin Money Flow: | 7578 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (54.53 - 56.93) | Buy |
Bollinger Bands (100): | (43.84 - 54.24) | Buy |
RARE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.8 | Buy |
Relative Strength Index (14 RSI): | 43.18 | Sell |
Chaikin Money Flow: | -435004 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (55.76 - 58.26) | Sell |
Bollinger Bands (100): | (40.14 - 54.08) | Buy |
HTLF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 56.83 | Sell |
20-day SMA: | 55.84 | Buy |
50-day SMA: | 53.65 | Buy |
200-day SMA: | 42.33 | Buy |
8-day EMA: | 56.3 | Sell |
20-day EMA: | 55.72 | Buy |
50-day EMA: | 53.28 | Buy |
200-day EMA: | 44.64 | Buy |
RARE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 57.08 | Sell |
20-day SMA: | 56.96 | Sell |
50-day SMA: | 52.99 | Buy |
200-day SMA: | 46.88 | Buy |
8-day EMA: | 56.5 | Sell |
20-day EMA: | 56.46 | Sell |
50-day EMA: | 53.4 | Buy |
200-day EMA: | 47.32 | Buy |
Heartland Financial USA Earnings Growth & HTLF Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, an increase next quarter of $0.02 per share, an increase this year of $0.14 per share, and a decrease next year of $0.03 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.53 per share, an increase next quarter of $0.18 per share, an increase this year of $1.07 per share, and an increase next year of $1.02 per share.
Heartland Financial USA Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ultragenyx Pharmaceutical Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |